Bruker this week reported a 29 percent jump in first-quarter revenues year over year, posting $357 million in revenues, compared to $277.7 million in the first quarter of 2010.

The company's Bruker Scientific Instruments Segment, which contains its mass spectrometry products, saw revenues climb to $335.8 million, a 29 percent rise from $260.3 million a year ago.

In a statement, Bruker President and CEO Frank Laukien said that new order bookings increased 40 percent year over year, and the firm ended the first quarter with a new backlog record.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.